154 related articles for article (PubMed ID: 27489079)
1. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome.
Zhang R; Liu H; Bai H; Zhang Y; Liu Q; Guan L; Fan P
Clin Endocrinol (Oxf); 2017 Jan; 86(1):88-96. PubMed ID: 27489079
[TBL] [Abstract][Full Text] [Related]
2. Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in southwest Chinese women with polycystic ovary syndrome.
Liu HW; Zhang F; Fan P; Bai H; Zhang JX; Wang Y
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):146-51. PubMed ID: 23746632
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome.
Zhang J; Zhang Y; Liu H; Bai H; Wang Y; Jiang C; Fan P
Fertil Steril; 2015 May; 103(5):1346-54. PubMed ID: 25813288
[TBL] [Abstract][Full Text] [Related]
4. Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.
Zhang R; Song Q; Liu H; Bai H; Zhang Y; Liu Q; Guan L; Fan P
Lipids Health Dis; 2017 Mar; 16(1):57. PubMed ID: 28320416
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].
Rehme MF; Pontes AG; Corrente JE; Franco JG; Pontes A
Rev Bras Ginecol Obstet; 2013 Dec; 35(12):562-8. PubMed ID: 24500511
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.
Cakir E; Ozbek M; Ozkaya E; Colak N; Cakal E; Sayki M; Gungunes A; Aliyazicioglu Y; Mentese A; Delibasi T
J Endocrinol Invest; 2011; 34(7):e178-82. PubMed ID: 21088474
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.
Guo M; Chen ZJ; Macklon NS; Shi YH; Westerveld HE; Eijkemans MJ; Fauser BC; Goverde AJ
Reprod Biomed Online; 2010 Oct; 21(4):572-80. PubMed ID: 20800551
[TBL] [Abstract][Full Text] [Related]
11. Follicular fluid redox balance and DNA damage according to PCOS phenotype.
Onal M; Agar M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5583-5589. PubMed ID: 37401295
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome.
Blair SA; Kyaw-Tun T; Young IS; Phelan NA; Gibney J; McEneny J
J Reprod Med; 2013; 58(3-4):107-14. PubMed ID: 23539878
[TBL] [Abstract][Full Text] [Related]
13. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
15. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women.
Liu Q; Liu H; Bai H; Huang W; Zhang R; Tan J; Guan L; Fan P
J Endocrinol Invest; 2019 Aug; 42(8):909-921. PubMed ID: 30607774
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome.
Sun Y; Li S; Liu H; Bai H; Hu K; Zhang R; Liu Q; Fan P
Fertil Steril; 2021 Dec; 116(6):1641-1650. PubMed ID: 34433519
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
Li R; Zhang Q; Yang D; Li S; Lu S; Wu X; Wei Z; Song X; Wang X; Fu S; Lin J; Zhu Y; Jiang Y; Feng HL; Qiao J
Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
[TBL] [Abstract][Full Text] [Related]
20. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
